Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
shaS90qGRbf1qtf1